Zoetis
ZTS
$1.91 (1.30%)
1D
1W
3M
1Y
5Y
ALL
Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests and precision livestock farming technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
The Motley Fool • 15 days ago • ZTS
This Magnificent Dividend Stock Has Increased Its Payouts by 500% in 10 YearsSeeking Alpha • 16 days ago • ZTS
My Top 15 High-Growth Dividend Stocks For April 2025The Motley Fool • 22 days ago • ZTS
Zoetis' Stock Is About as Cheap as It's Ever Been. 1 Thing to Know Before You Buy.Business Wire • 22 days ago • ZTS
Zoetis to Host Webcast and Conference Call on First Quarter 2025 Financial ResultsSeeking Alpha • 24 days ago • ZTS
Zoetis: Lots Of Growth Opportunities For This High-Quality CompounderCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.